Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.
Identifieur interne : 000532 ( PubMed/Checkpoint ); précédent : 000531; suivant : 000533Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.
Auteurs : D L Murray ; D T Imagawa ; D M Okada ; J W St GemeSource :
- Journal of clinical microbiology [ 0095-1137 ] ; 1979.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Anticorps antiviraux (biosynthèse), Anticorps hétérophiles (biosynthèse), Complications de la grossesse et maladies infectieuses (), Femelle, Grippe humaine (), Grossesse, Humains, Immunoglobuline M (biosynthèse), Tests d'inhibition de l'hémagglutination, Vaccins antigrippaux (immunologie), Virus de la grippe A (immunologie).
- MESH :
English descriptors
- KwdEn :
- Adolescent, Adult, Antibodies, Heterophile (biosynthesis), Antibodies, Viral (biosynthesis), Female, Hemagglutination Inhibition Tests, Humans, Immunoglobulin M (biosynthesis), Influenza A virus (immunology), Influenza Vaccines (immunology), Influenza, Human (prevention & control), Pregnancy, Pregnancy Complications, Infectious (prevention & control).
- MESH :
- chemical , biosynthesis : Antibodies, Heterophile, Antibodies, Viral, Immunoglobulin M.
- immunology : Influenza A virus, Influenza Vaccines.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- Adolescent, Adult, Female, Hemagglutination Inhibition Tests, Humans, Pregnancy.
Abstract
The decision to implement a mass immunization program with A/New Jersey/8/76 (Hsw1N1) influenza vaccine provided a unique opportunity to evaluate immunological responses during pregnancy. Fifty-nine pregnant and 27 nonpregnant women participated in this study. Influenza virus hemagglutination-inhhibition antibody titers were determined to A/New Jersey/8/76 (Hsw1N1), A/Japan/305/57 (H2N2), and A/Hong Kong/8/68 (H3N2) before and after a single dose of monovalent (200 chick cell agglutination units) influenza A/New Jersey/8/76 (Hsw1N1) vaccine. The difference in titers between pregnant and nonpregnant women was insignificant. Treatment of the sera with 2-mercaptoethanol disclosed a similar immunoglobulin M response to the vaccine in both groups. The mean fold rise in heterologous antibody titer was similar in pregnant and nonpregnant women. This study demonstrated that pregnant women were able to respond to an original myxovirus antigen, influenza A/New Jersey/8/76, in a manner equivalent to nonpregnant, age-matched controls.
PubMed: 583151
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:583151Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.</title><author><name sortKey="Murray, D L" sort="Murray, D L" uniqKey="Murray D" first="D L" last="Murray">D L Murray</name></author><author><name sortKey="Imagawa, D T" sort="Imagawa, D T" uniqKey="Imagawa D" first="D T" last="Imagawa">D T Imagawa</name></author><author><name sortKey="Okada, D M" sort="Okada, D M" uniqKey="Okada D" first="D M" last="Okada">D M Okada</name></author><author><name sortKey="St Geme, J W" sort="St Geme, J W" uniqKey="St Geme J" first="J W" last="St Geme">J W St Geme</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1979">1979</date><idno type="RBID">pubmed:583151</idno><idno type="pmid">583151</idno><idno type="wicri:Area/PubMed/Corpus">000604</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000604</idno><idno type="wicri:Area/PubMed/Curation">000604</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000604</idno><idno type="wicri:Area/PubMed/Checkpoint">000532</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000532</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.</title><author><name sortKey="Murray, D L" sort="Murray, D L" uniqKey="Murray D" first="D L" last="Murray">D L Murray</name></author><author><name sortKey="Imagawa, D T" sort="Imagawa, D T" uniqKey="Imagawa D" first="D T" last="Imagawa">D T Imagawa</name></author><author><name sortKey="Okada, D M" sort="Okada, D M" uniqKey="Okada D" first="D M" last="Okada">D M Okada</name></author><author><name sortKey="St Geme, J W" sort="St Geme, J W" uniqKey="St Geme J" first="J W" last="St Geme">J W St Geme</name></author></analytic><series><title level="j">Journal of clinical microbiology</title><idno type="ISSN">0095-1137</idno><imprint><date when="1979" type="published">1979</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Antibodies, Heterophile (biosynthesis)</term><term>Antibodies, Viral (biosynthesis)</term><term>Female</term><term>Hemagglutination Inhibition Tests</term><term>Humans</term><term>Immunoglobulin M (biosynthesis)</term><term>Influenza A virus (immunology)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Anticorps antiviraux (biosynthèse)</term><term>Anticorps hétérophiles (biosynthèse)</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grossesse</term><term>Humains</term><term>Immunoglobuline M (biosynthèse)</term><term>Tests d'inhibition de l'hémagglutination</term><term>Vaccins antigrippaux (immunologie)</term><term>Virus de la grippe A (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Antibodies, Heterophile</term><term>Antibodies, Viral</term><term>Immunoglobulin M</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Anticorps antiviraux</term><term>Anticorps hétérophiles</term><term>Immunoglobuline M</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Female</term><term>Hemagglutination Inhibition Tests</term><term>Humans</term><term>Pregnancy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Complications de la grossesse et maladies infectieuses</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Tests d'inhibition de l'hémagglutination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The decision to implement a mass immunization program with A/New Jersey/8/76 (Hsw1N1) influenza vaccine provided a unique opportunity to evaluate immunological responses during pregnancy. Fifty-nine pregnant and 27 nonpregnant women participated in this study. Influenza virus hemagglutination-inhhibition antibody titers were determined to A/New Jersey/8/76 (Hsw1N1), A/Japan/305/57 (H2N2), and A/Hong Kong/8/68 (H3N2) before and after a single dose of monovalent (200 chick cell agglutination units) influenza A/New Jersey/8/76 (Hsw1N1) vaccine. The difference in titers between pregnant and nonpregnant women was insignificant. Treatment of the sera with 2-mercaptoethanol disclosed a similar immunoglobulin M response to the vaccine in both groups. The mean fold rise in heterologous antibody titer was similar in pregnant and nonpregnant women. This study demonstrated that pregnant women were able to respond to an original myxovirus antigen, influenza A/New Jersey/8/76, in a manner equivalent to nonpregnant, age-matched controls.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">583151</PMID><DateCompleted><Year>1980</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0095-1137</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>1979</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J. Clin. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.</ArticleTitle><Pagination><MedlinePgn>184-7</MedlinePgn></Pagination><Abstract><AbstractText>The decision to implement a mass immunization program with A/New Jersey/8/76 (Hsw1N1) influenza vaccine provided a unique opportunity to evaluate immunological responses during pregnancy. Fifty-nine pregnant and 27 nonpregnant women participated in this study. Influenza virus hemagglutination-inhhibition antibody titers were determined to A/New Jersey/8/76 (Hsw1N1), A/Japan/305/57 (H2N2), and A/Hong Kong/8/68 (H3N2) before and after a single dose of monovalent (200 chick cell agglutination units) influenza A/New Jersey/8/76 (Hsw1N1) vaccine. The difference in titers between pregnant and nonpregnant women was insignificant. Treatment of the sera with 2-mercaptoethanol disclosed a similar immunoglobulin M response to the vaccine in both groups. The mean fold rise in heterologous antibody titer was similar in pregnant and nonpregnant women. This study demonstrated that pregnant women were able to respond to an original myxovirus antigen, influenza A/New Jersey/8/76, in a manner equivalent to nonpregnant, age-matched controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>D L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Imagawa</LastName><ForeName>D T</ForeName><Initials>DT</Initials></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>St Geme</LastName><ForeName>J W</ForeName><Initials>JW</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000910">Antibodies, Heterophile</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000910" MajorTopicYN="N">Antibodies, Heterophile</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1979</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1979</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">583151</ArticleId><ArticleId IdType="pmc">PMC273125</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Assoc. 1959 Oct 10;171:638-41</Citation><ArticleIdList><ArticleId IdType="pubmed">13845103</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health Nations Health. 1961 Aug;51:1182-8</Citation><ArticleIdList><ArticleId IdType="pubmed">13711529</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 Dec;136 Suppl:S722-30</Citation><ArticleIdList><ArticleId IdType="pubmed">606797</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 Dec;136 Suppl:S686-92</Citation><ArticleIdList><ArticleId IdType="pubmed">606792</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 Dec;136 Suppl:S665-71</Citation><ArticleIdList><ArticleId IdType="pubmed">342632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 Dec;136 Suppl:S450-5</Citation><ArticleIdList><ArticleId IdType="pubmed">342620</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 Dec;136 Suppl:S435-42</Citation><ArticleIdList><ArticleId IdType="pubmed">342618</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1976 Dec;61(6):925-31</Citation><ArticleIdList><ArticleId IdType="pubmed">1034440</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1971 May 10;216(6):1022-3</Citation><ArticleIdList><ArticleId IdType="pubmed">5108246</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 1972 Aug;81(2):217-30</Citation><ArticleIdList><ArticleId IdType="pubmed">5042481</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1967 Apr;98(4):668-72</Citation><ArticleIdList><ArticleId IdType="pubmed">4960650</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Obstet Gynecol. 1976 Mar;19(1):47-54</Citation><ArticleIdList><ArticleId IdType="pubmed">1253466</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 1971 Apr 1;109(7):971-6</Citation><ArticleIdList><ArticleId IdType="pubmed">5549342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Imagawa, D T" sort="Imagawa, D T" uniqKey="Imagawa D" first="D T" last="Imagawa">D T Imagawa</name><name sortKey="Murray, D L" sort="Murray, D L" uniqKey="Murray D" first="D L" last="Murray">D L Murray</name><name sortKey="Okada, D M" sort="Okada, D M" uniqKey="Okada D" first="D M" last="Okada">D M Okada</name><name sortKey="St Geme, J W" sort="St Geme, J W" uniqKey="St Geme J" first="J W" last="St Geme">J W St Geme</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000532 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000532 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:583151
|texte= Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:583151" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |